Clinical Trial Update: Study of ADXS-504 Immunotherapy for Recurrent Prostate Cancer [Phase 1]

View source ↗

Summary

This document reports a Phase 1 clinical trial update for ADXS-504 immunotherapy in patients with recurrent prostate cancer, noting the study is currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ADXS-504

Snippet

Sponsor: Mark Stein | Conditions: Recurrent Prostate Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING